Johns Hopkins Researchers To Follow ‘Nationally Representative Cohort’ Of 10,000 Marijuana Patients In Federally Funded Study

December 28, 2023 · Marijuana Moment

A new study by researchers at Johns Hopkins University will track 10,000 medical marijuana patients over a year or more in an effort to better understand the efficacy and impacts of cannabis therapy.

Funded with a five-year $10 million grant from the National Institute on Drug Abuse (NIDA), the research team will work with federal researchers and the nonprofit Realm of Caring, among others, to collect data around dosing, delivery methods, the chemical composition of products, possible medication interactions and other treatment details.

“Our mission with this research is to understand the health impacts of therapeutic cannabis use,” one of the study’s co-creators, Ryan Vandrey, a professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, said in a statement. “We hope to provide some starting points for understanding what types of products may or may not be helpful and what types of products may be more risky for use in certain populations or for certain therapeutic purposes.”

“Under the umbrella term of cannabis exist hundreds of products that are all different in very important and significant ways,” he added. “We’re trying to narrow the scope a little bit, find areas of real promise and focus the science on those.”

Despite a notable increase in published research around marijuana in recent years, obstacles to science caused by federal cannabis laws mean clinicians are playing still catch-up in a country where more than three-quarters of states have legalized the drug for medical use.

“We have the availability of cannabis as a therapeutic,” Vandry said, “but we’re lacking the quality of data that we have with other medicines.”

A Johns Hopkins press release says the National Cannabis Study, which is part of a larger Cannabis and Health Research Initiative, will follow the “nationally representative” cohort consisting of an estimated 10,000 patients “as they progress from cannabis naivety through a year or more of cannabis use.”

“We’re tracking them with multiple assessments over the course of their first year with more tightly spaced assessments toward the beginning because our assumption is that as people are starting their medical cannabis journey, they’re likely going to try different products until they find the products that best help them with their symptoms,” said Johannes Thrul, a project collaborator and mental health professor at the Johns Hopkins Bloomberg School of Public Health.

As the university pursues its own research initiative, the National Institutes of Health (NIH) recently posted a notice of funding opportunity announcing that it is looking for an entity to operate a new Resource Center for Cannabis and Cannabinoid Research through a cooperative agreement in order to “address challenges and barriers to conducting research on cannabis and its constituents.”

Addressing marijuana research barriers has been a key priority for multiple federal health agencies as scientists continue to face an onerous and costly registration process in order to access cannabis due to its current status as a Schedule I drug under the Controlled Substances Act (CSA).

That policy is actively under review by the Drug Enforcement Administration (DEA) following a U.S. Department of Health and Human Services (HHS) recommendation to move cannabis to Schedule III. (Full Story)

In category:Research
Next Post

DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024

The Drug Enforcement Administration (DEA) is now calling for the production of even more THC, psilocybin and DMT for research purposes than it initially proposed for 2024—raising its quotas for those drugs while maintaining already high production goals for marijuana and…
Previous Post

Despite Widespread Legalization, Fewer Young People Find it ‘Easy’ To Get Pot

The number of legal cannabis retailers has exploded in North America the last decade, but that hasn’t resulted in easier access for kids.  That is the takeaway from newly published survey data that examined perceptions of cannabis among youth in Canada.…
Random Post

State regulators want Congress to redefine, regulate hemp, delta-8 THC

An association of regulators of state cannabis programs is asking Congress to include in the next Farm Bill new rules governing hemp and hemp-derived cannabinoids, including a new definition for what constitutes “hemp” versus marijuana. If adopted, the proposed rules would have…
Random Post

Cannabis Companies Quietly Downsizing

Despite a quieting of headline-making layoffs in the cannabis industry over the past year, the industry continues to face challenges ranging from a robust illicit market to the lack of any progress on federal legislation. And as a result, cannabis…
Random Post

NCAA Considers Removing Cannabis from Drug Testing Protocols

The NCAA Committee on Competitive Safeguards and Medical Aspects of Sports (CMAS) last week indicated its support for removing cannabis from the association’s banned drug list and testing protocols. The committee will gather input from the membership this summer, with…
Random Post

South Dakota Proposes Adult Use Legistation

South Dakota is teeing up to be the next state to legalize adult-use cannabis. Attorney General Marty Jackley submitted the proposed measure to Secretary of State Monae Johnson on November 17. The draft summary of the measure was made public as…